MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS)
$3.564 0.068 (1.9451%)
Analysed MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) News Sources
TSX Opportunities GoldMining And 2 Other Promising Penny Stocks
13-02-2026
yahoo.com
February 2026's TSX Penny Stocks To Consider
13-02-2026
yahoo.com
Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation
15-04-2026
yahoo.com
3 TSX Penny Stocks With Market Caps Under CA$200M To Consider
15-05-2026
yahoo.com
Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada
09-06-2026
yahoo.com
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call
16-06-2026
yahoo.com
Micron Heads Into Earnings With Strong Signal
22-06-2026
yahoo.com
Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX (treosulfan) for Injection
25-06-2026
yahoo.com
Medexus Pharmaceuticals Inc (MEDXF) Q4 2026 Earnings Call Highlights: Navigating Challenges and ...
26-06-2026
yahoo.com
Medexus Schedules First Fiscal Quarter 2027 Conference Call
30-07-2026
yahoo.com
What is the current price of MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS)?
The current price of MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) is $3.564.
MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) since the previous trading day is $0.068.
MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) since the previous trading day is 1.9451%.
What is the most recent average sentiment score for MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS)?
The most recent average sentiment score for MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) is 83 out of 100.
What is the most recent average sentiment for MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS)?
The most recent sentiment for MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) is .
SEC-8K** Filing Available For MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.